Medical News

RSS

Mylan announces launch of Esomeprazole Magnesium Delayed-release Capsules USP in U.S.

Mylan N.V. today announced the U.S. launch of Esomeprazole Magnesium Delayed-release Capsules USP, 20 mg and 40 mg, which is the generic version of AstraZeneca's Nexium.

6 Aug 2015

Autoantibody status fails to predict death risk in systemic sclerosis with PAH

Anticentromere and isolated nucleolar autoantibodies are prevalent in systemic sclerosis patients with pulmonary arterial hypertension, but they do not predict survival, US research shows.

5 Aug 2015

Structural brain changes found in chemoradiation-treated glioblastoma patients

US researchers find evidence of marked and progressive brain atrophy during standard chemoradiation therapy in patients with glioblastoma.

5 Aug 2015

Hedgehog blockade promising in myeloid malignancies

Phase I trial results published in The Lancet Haematology show that the hedgehog signalling pathway antagonist PF-04449913 is tolerable and has activity in patients with haematological cancers.

5 Aug 2015

Poor relapse recovery heralds progressive MS

Multiple sclerosis patients with poor recovery from relapses develop the progressive form faster than those with good recovery, research shows.

5 Aug 2015

Chronic inflammatory demyelinating polyneuropathy commonly misdiagnosed

Half of patients referred to a specialist centre with a diagnosis of chronic inflammatory demyelinating polyneuropathy do not actually have the condition, report researchers.

5 Aug 2015

Diaphragmatic pacing ’harmful’ in amyotrophic lateral sclerosis

Diaphragmatic pacing in conjunction with non-invasive ventilation is detrimental to patients with amyotrophic lateral sclerosis and respiratory insufficiency, show findings from a randomised controlled trial.

5 Aug 2015

Lucideon and ReBioStent project partners to host Bioresorbable Materials for Medical Applications session at ESB 2015

Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, “Bioresorbable Materials for Medical Applications”, at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.

From Lucideon 5 Aug 2015

First drug produced by 3D printing is approved by FDA

Levetiracetam manufactured using three-dimensional (3D) printing has been approved by the US Food and Drug Administration (FDA) for the treatment of epilepsy.

5 Aug 2015

Oral contraceptives give long-term protection against endometrial cancer, shows study

Use of oral contraceptives, even for just a few years, gives substantial long-term protection against endometrial cancer, and the longer the pill is used the greater the reduction in risk, according to a detailed re-analysis of all the available evidence, published in The Lancet Oncology journal.

5 Aug 2015

Delcath Systems achieves record quarterly product revenue in Q2 2015

Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces financial results for the three and six months ended June 30, 2015.

5 Aug 2015

Cardiome Pharma reports net loss of $7.4 million in second quarter 2015

Cardiome Pharma Corp. today reported financial results for the second quarter and six months ended June 30, 2015. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP).

5 Aug 2015

TSRI study shows single injection of blebbistatin drug prevents methamphetamine relapse in animal models

Recovering addicts often grapple with the ghosts of their addiction—memories that tempt them to relapse even after rehabilitation and months, or even years, of drug-free living.

5 Aug 2015

Breakthrough initiative aims at empowering Americans to make better food choices

Empowering Americans to make better food choices is the goal of a breakthrough initiative between the American Heart Association, the nation's largest voluntary organization dedicated to fighting heart disease and stroke, and Aramark, the largest U.S.-based food service provider.

5 Aug 2015

Charity and uncompensated care spending vary greatly among not-for-profit hospitals

While not-for-profit hospitals receive substantial tax benefits, some do not provide free or subsidized care for a higher percentage of patients living in poverty than their for-profit counterparts, according to a study of California medical centers.

5 Aug 2015

In vitro testing provides proof of concept for osteopathic manipulative therapy

In vitro studies of the cellular effects of modeled osteopathic manipulative therapy (OMT) provide proof of concept for the manual techniques practiced by doctors of osteopathic medicine (DOs), according to researchers from the University of Arizona College of Medicine - Phoenix.

5 Aug 2015

New biosensors detect efficient microbial workers that produce chemical, pharmaceutical commodities

Super productive factories of the future could employ fleets of genetically engineered bacterial cells, such as common E. coli, to produce valuable chemical commodities in an environmentally friendly way.

5 Aug 2015

Health Care DataWorks acquired by Health Catalyst

Health Catalyst, a leader in healthcare data warehousing, analytics and outcomes improvement, announced today that it has acquired Health Care DataWorks (HCD), a leading provider of business intelligence for health systems.

5 Aug 2015

LifeBond announces closure of $27M Series D preferred equity investment

LifeBond, a leader in the development of bio-surgical medical devices for tissue repair, announced today it has closed a $27M Series D preferred equity investment. Participants in the round include Pitango Venture Capital, Adams Street Partners, Sino Biopharmaceutical Ltd., and all existing investors.

5 Aug 2015

Hetero Group launches biosimilar 'Rituximab' under brand name MABALL in India

Hetero Group, one of India's leading generic pharmaceutical companies and one of the world's largest global producer of anti-retroviral drugs for HIV/AIDS treatment, today announces the successful launch of its biosimilar 'Rituximab' under the brand name MABALL in India.

5 Aug 2015

Medical News

Mylan announces launch of Esomeprazole Magnesium Delayed-release Capsules USP in U.S.

Autoantibody status fails to predict death risk in systemic sclerosis with PAH

Structural brain changes found in chemoradiation-treated glioblastoma patients

Hedgehog blockade promising in myeloid malignancies

Poor relapse recovery heralds progressive MS

Chronic inflammatory demyelinating polyneuropathy commonly misdiagnosed

Diaphragmatic pacing ’harmful’ in amyotrophic lateral sclerosis

Lucideon and ReBioStent project partners to host Bioresorbable Materials for Medical Applications session at ESB 2015

First drug produced by 3D printing is approved by FDA

Oral contraceptives give long-term protection against endometrial cancer, shows study

Delcath Systems achieves record quarterly product revenue in Q2 2015

Cardiome Pharma reports net loss of $7.4 million in second quarter 2015

TSRI study shows single injection of blebbistatin drug prevents methamphetamine relapse in animal models

Breakthrough initiative aims at empowering Americans to make better food choices

Charity and uncompensated care spending vary greatly among not-for-profit hospitals

In vitro testing provides proof of concept for osteopathic manipulative therapy

New biosensors detect efficient microbial workers that produce chemical, pharmaceutical commodities

Health Care DataWorks acquired by Health Catalyst

LifeBond announces closure of $27M Series D preferred equity investment

Hetero Group launches biosimilar 'Rituximab' under brand name MABALL in India

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News